0.588

3.43% -0.0209

After Hours: .54 -0.048 -8.16%

Icecure Medical Ltd (ICCM)

Overview News Price History Discussions Forecast Stock Split

Icecure Medical Ltd stock is traded at $0.588, with a volume of 678.28K. It is down -3.43% in the last 24 hours and down -2.28% over the past month. Icecure Medical Ltd is a commercial-stage medical device company. The company is engaged in the research, development, and marketing of cryoablation systems and technologies based on liquid nitrogen, or LN2, for treating tumors. Its cryoablation technology is a minimally invasive alternative to surgical intervention for tumors, including those found in the breast, lungs, kidneys, bones, and other indications.

Previous Close:

$0.6089

Open:

$0.62

24h Volume:

678.28K

Relative Volume:

2.30

Market Cap:

$43.00M

Revenue:

$3.38M

Net Income/Loss:

$-15.06M

P/E Ratio:

-2.5075

EPS:

-0.2345

Net Cash Flow:

$-15.50M

1W Performance:

-2.02%

1M Performance:

-2.28%

6M Performance:

-42.91%

1Y Performance:

-50.17%

1-Day Range:

$0.5684

$0.6341

1-Week Range:

$0.5684

$0.64

52-Week Range:

$0.5401

$1.40

Icecure Medical Ltd Stock (ICCM) Company Profile

Name

Icecure Medical Ltd

Sector

Healthcare (1114)

Industry

Medical Devices (143)

Phone

Address

Employee

Twitter

Next Earnings Date

2026-03-17

Latest SEC Filings

ICCM's Discussions on Twitter

Compare ICCM vs ABT, SYK, MDT, BSX, EW

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
ICCM Icecure Medical Ltd	0.588	44.52M	3.38M	-15.06M	-15.50M	-0.2345
ABT Abbott Laboratories	104.83	180.82B	44.33B	6.50B	7.40B	3.717
SYK Stryker Corp	327.65	125.72B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	87.89	111.16B	35.48B	4.64B	5.41B	3.582
BSX Boston Scientific Corp	69.78	101.28B	20.08B	2.89B	3.66B	1.9391
EW Edwards Lifesciences Corp	82.67	47.45B	6.07B	1.06B	1.34B	1.8063

Icecure Medical Ltd (ICCM)

Icecure Medical Ltd Stock (ICCM) Company Profile

Compare ICCM vs ABT, SYK, MDT, BSX, EW

Icecure Medical Ltd Stock (ICCM) Latest News

[Form 3] IceCure Medical Ltd. Initial S... - Stock Titan

Huang Yang reports RSUs and options in IceCure Medical (NASDAQ: ICCM) - Stock Titan

IceCure Medical (NASDAQ: ICCM) director Chan Vincent Chun Hung files Form 3 - Stock Titan

IceCure Medical (ICCM) VP discloses shares, RSUs and option grants - Stock Titan

IceCure Medical (ICCM) COO discloses share, option and RSU stakes - Stock Titan

IceCure Medical (ICCM) VP details RSUs and stock option grants - Stock Titan

IceCure Medical (ICCM) CFO details shares, RSUs and options in Form 3 - Stock Titan

IceCure Medical (ICCM) director discloses shares and options in Form 3 - Stock Titan

IceCure Medical (ICCM) VP Naum Muchnik details insider share and option holdings - Stock Titan

IceCure Medical (ICCM) VP details share, option and RSU holdings - Stock Titan

IceCure Medical (ICCM) CEO details share, RSU and option stakes - Stock Titan

IceCure Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study: 89.4% and 83.9% Recurrence-Free Rates - Bitget

IceCure Medical Posts Strong 5-Year Kidney Cancer Cryoablation Data From ICESECRET Trial - TipRanks

IceCure Medical Ltd Reports Positive 5-Year Top-Line Results from ICESECRET Kidney Cancer Cryoablation Study - marketscreener.com

IceCure Medical (ICCM) Reports Positive Outcomes in Kidney Cance - GuruFocus

IceCure Medical (Nasdaq: ICCM) unveils 5-year kidney cancer data - Stock Titan

IceCure names Meir Peleg as CFO - Medical Buyer

[EFFECT] IceCure Medical Ltd. SEC Filing - Stock Titan

IceCure Medical Names New CFO and Plans Key Leadership Changes Amid ProSense® Growth - TipRanks

IceCure Medical (NASDAQ: ICCM) hires Meir Peleg as new CFO - Stock Titan

IceCure Medical Ltd. Appoints Meir Peleg as Chief Financial Officer, Effective May 17, 2026 - marketscreener.com

[EFFECT] IceCure Medical Ltd.... | ICCM SEC FilingForm EFFECT - Stock Titan

Dip Buying: Is IceCure Medical Ltd subject to activist investor interest2026 Selloffs & Precise Buy Zone Identification - baoquankhu1.vn

Published on: 2026-03-22 01:37:56 - baoquankhu1.vn

Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic U.S. ... By GuruFocus - Investing.com Canada

Ideas Watch: What dividend growth rate does IceCure Medical Ltd offerM&A Rumor & Breakout Confirmation Trade Signals - baoquankhu1.vn

Icecure Medical Ltd (ICCM) Q4 2025 Earnings Call Highlights: Rec - GuruFocus

IceCure Medical (NASDAQ: ICCM) registers $100M shelf for shares and warrants - Stock Titan

IceCure Medical (NASDAQ: ICCM) registers 9.74M shares from outstanding warrants - Stock Titan

History Review: Is IceCure Medical Ltd stock a good dividend stock2026 Volume & Weekly Watchlist for Hot Stocks - baoquankhu1.vn

ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 earnings call transcript - MSN

IceCure Medical Ltd (NASDAQ:ICCM) Q4 2025 Earnings Call Transcript - Insider Monkey

IceCure reports net loss of USD 15,057,000 in 2025 - Medical Buyer

Icecure Medical Rides FDA, ASBRS Wins to Growth - TipRanks

IceCure Medical Discloses Resignation of Director Li Haixiang - TipRanks

IceCure Medical (ICCM) director Li Haixiang steps down from board - Stock Titan

IceCure Medical (ICCM) Q4 2025 Earnings Transcript - AOL.com

IceCure Medical Ltd Announces Resignation of Li Haixiang as Member of the Board of Directors, Effective March 17, 2026 - marketscreener.com

IceCure Medical 2025 Financial Results Review | ProSense System UpdatesNews and Statistics - IndexBox

IceCure Medical (ICCM) Fourth Quarter 2025 Earnings Call Transcript - Bitget

IceCure Medical Ltd Q4 2025 Earnings Call Summary - Yahoo Finance

ICCM: Record revenue and regulatory milestones drive rapid adoption and expansion for ProSense - TradingView

ICCM: Record revenue and regulatory milestones fuel rapid adoption and growth outlook for ProSense - TradingView

IceCure Medical Ltd Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com

ICCM Reports Record FY25 Revenue Growth Following Key FDA Cleara - GuruFocus

IceCure Reports 2025 Full Year Financial & Operational Results - GuruFocus

IceCure Medical Posts Record 2025 Sales as ProSense Cryoablation Adoption Accelerates Post-FDA Clearance - TipRanks

Icecure Medical Ltd reports results for the quarter ended December 31Earnings Summary - TradingView

IceCure Medical (Nasdaq: ICCM) posts record 2025 revenue but $15.1M loss - Stock Titan

IceCure Medical (NASDAQ: ICCM) 20-F details going concern risk and FDA breast cancer OK - Stock Titan

Icecure Medical Ltd Stock (ICCM) Financials Data

Revenue

Net Income

Cash Flow

EPS

Similar to ICCM